- Home
- EVH vs NVCT Comparison
EVH vs NVCT Comparison
Compare EVH & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVH | NVCT |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.2M | 220.0M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVH | NVCT |
|---|---|---|
| Price | $2.30 | $7.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | $7.93 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 2.7M | 51.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,957,000.00 | N/A |
| Revenue This Year | $33.89 | N/A |
| Revenue Next Year | $15.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $5.55 |
| 52 Week High | $11.92 | $11.52 |
Technical Indicators
Market Signals| Indicator | EVH | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 36.67 | 36.50 |
| Support Level | N/A | $7.23 |
| Resistance Level | $4.20 | $8.46 |
| Average True Range (ATR) | 0.19 | 0.40 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 18.05 | 24.36 |
Price Performance
Historical ComparisonAbout EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.